| Name | Sutimlimab |
|---|
| Description | Sutimlimab, a first-in-class complement protein component 1, s subcomponent (C1s) inhibitor, can be used for the research of cold agglutinin disease. C1s is a serine protease which cleaves C4 and C2 to form the C3 convertase[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |